These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 87051)

  • 21. [The role of tissue steroids in benign hyperplasia and prostate cancer].
    Voigt KD; Bartsch W
    Urologe A; 1987 Nov; 26(6):349-57. PubMed ID: 2448941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spectrographic determination of zinc in the tissues of adenoma and carcinoma of the prostate.
    Romics I; Katchalova L
    Int Urol Nephrol; 1983; 15(2):171-6. PubMed ID: 6195123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low 25-OH vitamin D is associated with benign prostatic hyperplasia.
    Haghsheno MA; Mellström D; Behre CJ; Damber JE; Johansson H; Karlsson M; Lorentzon M; Peeker R; Barret-Connor E; Waern E; Sundh V; Ohlsson C; Hammarsten J
    J Urol; 2013 Aug; 190(2):608-14. PubMed ID: 23399651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization and measurement of the androgen receptor in human benign prostatic hyperplasia and prostatic hyperplasia and prostatic carcinoma.
    Snochowski M; Pousette A; Ekman P; Bression D; Andersson L; Högberg B; Gustafsson JA
    J Clin Endocrinol Metab; 1977 Nov; 45(5):920-30. PubMed ID: 72758
    [No Abstract]   [Full Text] [Related]  

  • 25. [Importance of determining steroid hormone receptors and the treatment of prostatic cancer].
    Fedotov IA; Denisov LE; Kozlov VP; Degtiar' VG
    Urol Nefrol (Mosk); 1983; (1):63-70. PubMed ID: 6187115
    [No Abstract]   [Full Text] [Related]  

  • 26. Biologically active steroids activate receptor-bound human sex hormone-binding globulin to cause LNCaP cells to accumulate adenosine 3',5'-monophosphate.
    Nakhla AM; Khan MS; Rosner W
    J Clin Endocrinol Metab; 1990 Aug; 71(2):398-404. PubMed ID: 2166070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative analysis of epidermal growth factor in human benign prostatic hyperplasia and prostatic carcinoma and its prognostic significance.
    Shaikh N; Lai L; McLoughlin J; Clark D; Williams G
    Anticancer Res; 1990; 10(4):873-4. PubMed ID: 1696447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DHT concentrations in human prostate cancer tissue.
    Geller J; Albert J; Loza D; Geller S; Stoeltzing W; de la Vega D
    J Clin Endocrinol Metab; 1978 Mar; 46(3):440-4. PubMed ID: 87401
    [No Abstract]   [Full Text] [Related]  

  • 29. [Study of zinc using X-ray scattering and transmission electron microscopy in human prostatic and neoplastic cells].
    Muñoz C; López A; Vilches J; Gómez S
    Actas Urol Esp; 1985; 9(2):185-90. PubMed ID: 2409753
    [No Abstract]   [Full Text] [Related]  

  • 30. Sex hormone-binding globulin is a significant predictor of extracapsular extension in men undergoing radical prostatectomy.
    Salonia A; Gallina A; Briganti A; Zanni G; Suardi N; Capitanio U; Colombo R; Bertini R; Freschi M; Guazzoni G; Rigatti P; Montorsi F
    BJU Int; 2011 Apr; 107(8):1243-9. PubMed ID: 20883480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Androgen-binding proteins in human benign prostatic hypertrophy.
    Rosen V; Jung I; Baulieu EE; Robel P
    J Clin Endocrinol Metab; 1975 Oct; 41(4):761-70. PubMed ID: 51854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dihydrotestosterone concentration in prostate cancer tissue as a predictor of tumor differentiation and hormonal dependency.
    Geller J; Albert J; de la Vega D; Loza D; Stoeltzing W
    Cancer Res; 1978 Nov; 38(11 Pt 2):4349-52. PubMed ID: 81107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of radix urticae extract and its several secondary extracts on blood SHBG in benign prostate hyperplasia].
    Schmidt K
    Fortschr Med; 1983 Apr; 101(15):713-6. PubMed ID: 6189775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methodologic basis for the radioimmunoassay of endogenous steroids in human prostatic tissue.
    Belis JA
    Invest Urol; 1980 Jan; 17(4):332-6. PubMed ID: 6153177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The binding of a potent synthetic androgen--methyltrienolone (R 1881)--to cytosol preparations of human prostatic cancer.
    Walsh PC; Greco JM; Tananis CE; Hicks LL; McLoughlin MG; Menon M
    Trans Am Assoc Genitourin Surg; 1977; 69():78-80. PubMed ID: 84428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A growth factor in extracts of human prostatic tissue.
    Lawson RK; Story MT; Jacobs SC
    Prog Clin Biol Res; 1981; 75A():325-36. PubMed ID: 6175979
    [No Abstract]   [Full Text] [Related]  

  • 37. Putative melatonin receptors in benign human prostate tissue.
    Laudon M; Gilad E; Matzkin H; Braf Z; Zisapel N
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1336-42. PubMed ID: 8636329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of extracts of the roots of the stinging nettle (Urtica dioica) on the interaction of SHBG with its receptor on human prostatic membranes.
    Hryb DJ; Khan MS; Romas NA; Rosner W
    Planta Med; 1995 Feb; 61(1):31-2. PubMed ID: 7700987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electrophoretic evaluation of different hormonal receptor sites in the prostate during anti-hormonal treatment and in response to hormones.
    Fischer DR; Gevers W
    Urol Int; 1979; 34(2):95-104. PubMed ID: 87051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Possibilities for the evaluation of receptor sites in benign prostatic hyperplasia and carcinoma of the prostate (author's transl)].
    Fischer D; Gevers W; Bressel M
    Urologe A; 1980 Nov; 19(6):326-30. PubMed ID: 6162265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.